tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

EKF Diagnostics Buys Back 200,000 Shares and Manages Major Shareholder’s Stake

Story Highlights
  • EKF Diagnostics repurchased 200,000 shares at 26 pence, now holding them in treasury.
  • Share buyback included 59,000 shares from Harwood-managed funds to keep Christopher Mills’ stake below 30%.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
EKF Diagnostics Buys Back 200,000 Shares and Manages Major Shareholder’s Stake

Claim 70% Off TipRanks Premium

EKF Diagnostics Holdings ( (GB:EKF) ) just unveiled an update.

EKF Diagnostics Holdings has repurchased 200,000 of its ordinary shares at 26 pence each, adding them to treasury and leaving 432,820,112 shares in issue carrying voting rights, a move that modestly adjusts its capital structure and may support earnings per share over time. As part of the buyback, the company acquired 59,000 shares from funds managed by Harwood to ensure that Non-Executive Director Christopher Mills’ aggregate indirect beneficial interest remains around, but does not exceed, 30% of EKF’s total voting rights, clarifying ownership dynamics for shareholders and regulators.

The most recent analyst rating on (GB:EKF) stock is a Hold with a £27.00 price target. To see the full list of analyst forecasts on EKF Diagnostics Holdings stock, see the GB:EKF Stock Forecast page.

Spark’s Take on GB:EKF Stock

According to Spark, TipRanks’ AI Analyst, GB:EKF is a Neutral.

EKF Diagnostics Holdings receives a score of 67, driven by strong financial performance and a positive earnings call. The company’s robust balance sheet and improved profitability are significant strengths. However, technical indicators suggest potential bearish momentum, and the valuation is moderate. The positive outlook from the earnings call, including strategic growth plans and a share buyback program, enhances the overall score.

To see Spark’s full report on GB:EKF stock, click here.

More about EKF Diagnostics Holdings

EKF Diagnostics Holdings is an AIM-listed global diagnostics business focused on point-of-care analysers in hematology and diabetes, as well as life sciences services that manufacture specialist enzymes and custom products for diagnostic, food and industrial applications. Headquartered in Penarth near Cardiff, the company operates five manufacturing sites across the US and Germany and sells into more than 120 countries worldwide.

Average Trading Volume: 457,160

Technical Sentiment Signal: Strong Sell

Current Market Cap: £112.2M

Learn more about EKF stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1